Revolution in lymphedema therapy
Lymphatica Medtech SA
Incorporated
20.07.2017Headquarters
Chavannes-près-RenensSupport
Lymphatica is a clinical stage medical device development company that has designed and patented the first implantable system for chronic lymphedema treatment, which will improve the quality of life of millions of patients in the world.
Chronic lymphedema is a common side effect of cancer therapies that causes chronic swelling of the limbs, pain and recurrent infections, leading to a state of chronic disability. More than 10 million people in Europe and US have lymphedema.
Lymphatica is a new hope for the patient and a new tool for healthcare specialists.
News
Lymphatica Medical raises €17.9 million in series B Funding (startupticker.ch)
Lymphatica Medtech raises EUR 17.9M in Series B to advance Lymphedema treatment (venturelab.swiss)
Lymphatica Medtech awarded FDA Breakthrough Device Designation (startupticker.ch)
Startups appoint industry mavens to their board of directors (startupticker.ch)
CHF 1.2M FIT Funding for Imverse, Isochronic & Lymphatica (startupticker.ch)
Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million (startupticker.ch)
15 startups contest to win CHF 100,000 (startupticker.ch)
Medtech start-ups enroute to transform the industry (startupticker.ch)
Accolades for healthtech solutions out of Switzerland (startupticker.ch)
Venture Leaders Life Sciences and Medtech pitch to an audience of international investors, VCs and experts in Harvard, Cambridge (venturelab.swiss)
Joint roadshow in Boston for Venture Leaders Life Sciences 2020 and Medtech 2021 (venturelab.swiss)
The Venture Leaders Medtech 2021 kick off their roadshow to connect with international investors (venturelab.swiss)
Meet Lymphatica Medtech co-founder Marco Pisano and find out how he improves the lives of people with lymphatic diseases (venturelab.swiss)
First Venture Leaders Medtech selected (startupticker.ch)
Venture Leaders Medtech 2021: 10 new members of the Swiss National Startup Team will represent Switzerland in Boston (venturelab.swiss)
Meet the 38 winners of the IMD Startup Competition (startupticker.ch)
Seven digit investment for Lymphatica (startupticker.ch)
Lymphatica Medtech raises Series A round to start the clinical development and validation (venturelab.swiss)
Ten healthcare startups compete for a ticket to the Silicon Valley (startupticker.ch)
Swiss National Startup Teams Welcomed by Chinese Ambassador After Their Roadshow to Hong Kong and China (venturelab.swiss)
Milestones news
LymphoDrain pilot clinical trial: 3 arm lymphedema patients successfully implanted with our device
Authorization to run clinical trials
Lymphatica is a Gold Winner at Mass Challenge
